Good morning. Competition continues to heat up in the rapidly growing business of weight loss, as drugmakers race to grab a share of the generic Ozempic market. We’ll be exploring this and much more ...

As the midterm election year gets underway, voters are already drawing clear lines between the Democratic and Republican parties on the issues. A new Fox News survey, released Thursday, finds the ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company plans to use an ...

NEW DELHI: In what could be good news for patients, Indian Patent Office (IPO) has rejected MNC AbbVie’s patent application for its blockbuster cancer drug Venetoclax citing lack of inventive step.

Dr Reddy’s Laboratories Ltd. is planning to launch a generic version of Ozempic in March after Novo Nordisk AS's patent for the drug expires. That would make the Indian drugmaker one of the first ...

Democrats are ahead of Republicans by 6 percentage points on a generic congressional ballot, according to a poll released Thursday. In the Emerson College poll, 48.1 percent of respondents backed a ...

Indian drugmaker Dr Reddy’s Laboratories Ltd is planning to launch a generic version of Novo Nordisk A/S’s Ozempic in March after the drug’s patent expiry, becoming one of the first firms to capture ...

Dr. Reddy’s Laboratories is gearing up to launch its generic version of semaglutide in India on March 21, positioning itself for an early mover advantage in one of the country’s largest chronic ...

HYDERABAD, Jan 21 (Reuters) - Indian drugmaker Dr Reddy's (REDY.NS), opens new tab, which reported a smaller-than-expected fall in quarterly profit on Wednesday, said that it has received an approval ...

The Democratic Party has a deeply motivated base and a clear advantage on the generic congressional ballot ahead of this fall’s midterms despite dismal impressions of its current leaders in Congress, ...

WASHINGTON, Jan 16 (Reuters) - The U.S. Supreme Court agreed on Friday to hear a patent dispute involving Amarin Pharma's (AMRN.O), opens new tab cardiovascular drug Vascepa that could have broad ...

Jithin (name changed) was an autorickshaw driver in Kerala, ferrying schoolchildren through the crowded lanes every morning and evening. His modest earnings barely covered food and his children’s ...